Subham Preetam is the Founder & CEO of N BASE. He is a professional biotechnologist in the field of biorobotics, cancer, immunity, biomedical, and nanometerial research. He is dedicated to the advancement of precision medicine and successful preclinical research to enhance the quality of life for individuals. With extensive cross-disciplinary training and experience in translational research, he is currently focused on various research topics, including microrobotics, soft bio-hybrid robots, and quantum nanoparticles for drug delivery. His research aims to improve the life expectancy of sea animals and humans. Furthermore, he is involved in developing a bio-fluidics nanomedicine system that leverages the latest drug delivery technologies to create personalized solutions for brain cancer patients in South Korea and Sweden. Additionally, he collaborates with researchers from India, Taiwan, Israel, US, Denmark, Singapore, Spain, Portugal, and the United Kingdom on various collaborative projects.
Initially funded by the European Commission’s Horizon 2020 programme, the first four ENABLE conferences were held in the cities hosting the headquarters of the four entities leading the project: the Institute for Research in Biomedicine (IRB Barcelona) in Barcelona, Spain; the Radboud Institute for Molecular Life Sciences (RIMLS) in Nijmegen, The Netherlands; The Novo Nordisk Foundation Center for Protein Research (CPR) in Copenhagen, Denmark; and the Scuola Europea di Medicina Molecolare (SEMM), in Milan, Italy. In this new cycle of conferences, FEBS, IUBMB and the four core ENABLE institutions have joined forces to share ENABLE best practices with other international research institutions. To this end, in addition to the four core research centres, other institutions can apply to become associated centres and host one of the events. For the 2024 event, FEBS-IUBMB-ENABLE will actively search for an associated centre in a non-European country to ensure that one of the events is held on another continent.
As a Senior Lecturer in Biomedical Science, I teach across several modules on the BSc (Hons) Biomedical Science programme. My research aims to uncover the mechanisms that protect the genetic integrity of both nuclear and mitochondrial DNA.
Cristina Blanco Sío-López
Marie Skłodowska-Curie Senior Global Fellow and Principal Investigator (PI); Executive Committee Member, GYA, Ca' Foscari University of Venice; Global Young Academy (GYA); Young Academy of Europe (YAE); Young Academy of Spain
Dr. Cristina Blanco Sío-López is Marie Skłodowska-Curie Senior Global Fellow and Principal Investigator (PI) of the EU Horizon 2020 research project ‘Navigating Schengen: Historical Challenges and Potentialities of the EU’s Free Movement of Persons, 1985-2015’ (NAVSCHEN) at the European Studies Center (ESC) – EU Jean Monnet European Centre of Excellence (JMEUCE) of the University of Pittsburgh (2019-2021) and at the Ca' Foscari University of Venice. She previously was Assistant Professor in European Culture and Politics at the University of Groningen and ‘Santander’ Senior Fellow in Iberian and European Studies at the European Studies Centre (ESC) – St. Antony’s College of the University of Oxford, where she remains a Senior Member. She is Executive Committee Member of the Global Young Academy (GYA), Fellow of the Young Academy of Europe (YAE) and Full Member of the Young Academy of Spain. She was Chair of the North America Chapter of the Marie Curie Alumni Association (MCAA) in 2020-2021, which received the ‘Best Non-European Chapter Award 2020’ by the MCAA. She obtained her PhD in History and Civilization (European Integration History) at the European University Institute of Florence (EUI) and received the FAEY Best PhD Thesis ‘European Research and Mobility’ Award in 2008.
James Perkins is a postdoctoral bioinformatics and computational biology researcher at the University of Malaga-IBIMA and the Spanish Rare Disease Biomedical Research Network (CIBERER). His research interests include omics-analysis, target prioritization, functional annotation, systems biology and disease-phenotype analysis, with a focus on rare disease.
I am a Professor of Toxicology, Biochemistry and Cell Signaling at Université Paris Cité (former Université Paris Descartes). I have completed my PhD in molecular toxicology and a post-graduate year in Bethesda, MD. I am the head of a Master degrees in toxicology and ecotoxicology. My research is based on cellular and animal models and on three main axes: 1) the influence of persistent organic pollutants on breast tumorigenesis and metabolic disruption, 2) the contextual role of pollutants in the occurrence of chronic liver diseases including steatosis and fibrosis, 3) the effect of mixtures on the progression of neurodegenerative diseases. I am involved in the development of innovative pedagogy methods and technics in order to improve transmission, acquisition, memorization and utilization of scientific knowledge by our biomedical students. I used flipped classrooms, quizzes (at home and during courses) and virtual reality to interact and immerge with students in and outside the classroom. Indeed, I developed with pedagogic engineers, 1) Home-based 45’’ Quizzes to engage students in regular learning modes and 2) serious games on cell signaling and xenobiotic stress. Together, with Etienne Blanc, Caroline Chauvet and Frédéric Dardel, I wrote several French books of biochemistry and toxicology topics for undergraduate students. I collaborate with several national and international institutes and universities (CNAM Thierry KOSCIELNIAK, Université de Strasbourg Jean-Luc SOUCIET, National University of Singapore, Fun Man FUNG...) for the development of innovative methods in teaching.